NCT03641560 2025-04-08
A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
Astellas Pharma Inc
Phase 4 Completed
Clinical Trials
11 trialsNCT04869488 2025-01-24
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT03776968 2024-10-23
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics
Hinova Pharmaceuticals Inc.
Phase 1 Completed
NCT05124795 2024-01-17
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
Immunic AG
Phase 1 Terminated
NCT03752099 2023-09-26
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Veru Inc.
Phase 1/2 Terminated
NCT04179396 2023-06-29
RAMP
pharmaand GmbH
Phase 1 Completed
NCT04634344 2022-07-11
Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC
Dizal Pharmaceuticals
Phase 1 Terminated
NCT03774056 2020-11-03
A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.
Hinova Pharmaceuticals Inc.
Phase 1 Completed
NCT03778047 2020-11-03
A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch
Hinova Pharmaceuticals Inc.
Phase 1 Completed
NCT04486937 2020-07-27
mCRPC
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 1/2 Unknown
NCT04056754 2019-08-14
Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Completed